STAT+: Novartis doubles down on molecular glue strategy

Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab

Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.

(MedPage Today) -- Note that some links may require registration or subscription. Health officials sounded the alarm on the presence of tularemia, or "rabbit fever," in northern Colorado. (USA Today via Yahoo!) The number of confirmed...

More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications

Proving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.